Epistaxis
50
2
3
27
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
13 trials with published results (26%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.0%
5 terminated out of 50 trials
84.4%
-2.1% vs benchmark
20%
10 trials in Phase 3/4
48%
13 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (50)
Sirolimus for Nosebleeds in HHT
Outcome of Hyaluronic Acid Gel Versus Petroleum Jelly in Treatment of Epistaxis
The Efficacy of Local Application of B-sitosterol Versus Vasline in Cases of Idiopathic Epistaxis
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
Comparison of Nasal Endotracheal Tube and Spiral Tube for Nasotracheal Intubation in Pediatric Patients
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal
Usage of Orange Peel Extract in Management of Epistaxis
Risk Factors of Epistaxis Recurrence in Adults
, "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"
NOVAPAK Nasal Packing in Shellfish Allergic Patients
Medico-economic Evaluation of Management Strategies for Severe Epistaxis
Xylometazoline and Cocaine for Nasal Vasoconstriction
Management of Persistent Epistaxis Using Floseal Hemostatic Matrix
Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
Nasal Ointment on Epistaxis of Nasotracheal Intubation in Children
NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial
Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department
The Effect of Bevel Direction on the Pathway of the Nasotracheal Tube
Intranasal Bevacizumab for HHT-Related Epistaxis